Mannan binding lectin as an adjunct to risk assessment for myocardial infarction in individuals with enhanced risk

Journal of Experimental Medicine

Volumn 201, Issue 1, 2005, Pages 117-125

  Saevarsdottir, Saedis ^a   Oskarsson, Oskar Orn ^a   Aspelund, Thor ^b   Eiriksdottir, Gudny ^b   Vikingsdottir, Thora ^a   Gudnason, Vilmundur ^b   Valdimarsson, Helgi ^a  

^a LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^b ICELANDIC HEART ASSOCIATION   (Iceland)

Author keywords

[No Author keywords available]

Indexed keywords

MANNAN BINDING LECTIN;

ADULT; AGED; ARTICLE; ATHEROGENESIS; CASE CONTROL STUDY; CHRONIC INFLAMMATION; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DRUG CLEARANCE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOLLOW UP; HEART INFARCTION; HIGH RISK POPULATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; ICELAND; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PHAGOCYTE; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK FACTOR; SMOKING; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DIABETES COMPLICATIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; ICELAND; INTERVIEWS; LOGISTIC MODELS; MALE; MANNOSE-BINDING LECTIN; MYOCARDIAL INFARCTION; ODDS RATIO; RISK ASSESSMENT; SMOKING; STATISTICS, NONPARAMETRIC;

EID: 12344289642     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20041431     Document Type: Article

References (50)

1. Ross, R. 1999. Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 340:115-126.
2. Erikssen, G., K. Liestol, J.V. Bjornholt, H. Stormorken, E. Thaulow, and J. Erikssen. 2000. Erythrocyte sedimentation rate: a possible marker of atherosclerosis and a strong predictor of coronary heart disease mortality. Eur. Heart J. 21:1614-1620.
3. Andresdottir, M.B., N. Sigfusson, H. Sigvaldason, and V. Gudnason. 2003. Erythrocyte sedimentation rate; an independent predictor of coronary heart disease in men and women. The Reykjavik Study. Am. J. Epidemiol. 158:844-851.
4. Danesh, J., J.G. Wheeler, G.M. Hirschfield, S. Eda, G. Eiriksdottir, A. Rumley, G.D. Lowe, M.B. Pepys, and V. Gudnason. 2004. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N. Engl. J. Med. 350:1387-1397.
5. Schifferli, J.A., Y.C. Ng, and D.K. Peters. 1986. The role of complement and its receptor in the elimination of immune complexes. N. Engl. J. Med. 315:488-495.
6. Prodinger, W.M., R. Würzner, H. Stoiber, and M.P. Dierich. 2003. Complement. In Fundamental Immunology. W.E. Paul, editor. Lippincott Williams & Wilkins, Philadelphia. 1077-1103.
7. Knolle, P.A., and G. Gerken. 2000. Local control of the immune response in the liver, Immunol. Rev. 174:21-34.
8. Nauta, A.J., N. Raaschou-Jensen, A. Roos, M.R. Daha, H.O. Madsen, M.C. Borrias-Essers, L.P. Ryder, C. Koch, and P. Garred. 2003. Mannose-binding lectin engagement with late apoptotic and necrotic cells. Eur. J. Immunol. 33:2853-2863.
9. Davies, K.A., K. Erlendsson, H.L. Beynon, A.M. Peters, K. Steinsson, H. Valdimarsson, and M.J. Walport. 1993. Splenic uptake of immune complexes in man is complement-dependent. J. Immunol. 151:3866-3873.
10. Petersen, S.V., S. Thiel, and J.C. Jensenius. 2001. The mannan-binding lectin pathway of complement activation: biology and disease association. Mol. Immunol. 38:133-149.
11. Saevarsdottir, S., T. Vikingsdottir, and H. Valdimarsson. 2004. The potential role of mannan-binding lectin in the clearance of self-components including immune complexes. Scand. J. Immunol. 60:23-29.
12. Gadjeva, M., K. Takahashi, and S. Thiel. 2004. Mannan-binding lectin-a soluble pattern recognition molecule. Mol. Immunol. 41:113-121.
13. Ogden, C.A., A. deCathelineau, P.R. Hoffmann, D. Bratton, B. Ghebrehiwet, V.A. Fadok, and P.M. Henson. 2001. C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J. Exp. Med. 194:781-795.
14. Kilpatrick, D.C. 1998. Phospholipid-binding activity of human mannan-binding lectin. Immunol. Lett. 61:191-195.
15. Sato, R., M. Matsushita, M. Miyata, Y. Sato, R. Kasukawa, and T. Fujita. 1997. Substances reactive with mannose-binding protein (MBP) in sera of patients with rheumatoid arthritis. Fukushima J. Med. Sci. 43:99-111.
16. Roos, A., L.H. Bouwman, D.J. van Gijlswijk-Janssen, M.C. Faber-Krol, G.L. Stahl, and M.R. Daha. 2001. Human IgA activates the complement system via the mannan-binding lectin pathway. J. Immunol. 167:2861-2868.
17. Saevarsdottir, S., T. Vikingsdottir, A. Vikingsson, V. Manfredsdottir, A.J. Geirsson, and H. Valdimarsson. 2001. Low mannose binding lectin predicts poor prognosis in patients with early rheumatoid arthritis. A prospective study. J. Rheumatol. 28:728-734.
18. Steffensen, R., S. Thiel, K. Vanning, C. Jersild, and J.C. Jensenius. 2000. Detection of structural gene mutations and promoter polymorphisms in the mannan-binding lectin (MBL) gene by polymerase chain reaction with sequence-specific primers. J. Immunol. Methods. 241:33-42.
19. Garred, P., F. Larsen, H.O. Madsen, and C. Koch. 2003. Mannose-binding lectin deficiency-revisited. Mol. Immunol. 40:73-84.
20. Fidler, K.J., P. Wilson, J.C. Davies, M.W. Turner, M.J. Peters, and N.J. Klein. 2004. Increased incidence and severity of the systemic inflammatory response syndrome in patients deficient in mannose-binding lectin. Intensive Care Med. 30:1438-1445.
21. Kilpatrick, D.C. 2002. Mannan-binding lectin: clinical significance and applications. Biochim. Biophys. Acta. 1572:401-413.
22. Neth, O., I. Hann, M.W. Turner, and N.J. Klein. 2001. Deficiency of mannose-binding lectin and burden of infection in children with malignancy: a prospective study. Lancet. 358:614-618.
23. Limnell, V., J. Aittoniemi, O. Vaarala, T. Lehtimaki, S. Laine, V. Virtanen, T. Palosuo, and A. Miettinen. 2002. Association of mannan-binding lectin deficiency with venous bypass graft occlusions in patients with coronary heart disease. Cardiology. 98:123-126.
24. Hegele, R.A., M.R. Ban, C.M. Anderson, and J.D. Spence. 2000. Infection-susceptibility alleles of mannose-binding lectin are associated with increased carotid plaque area. J. Investig. Med. 48:198-202.
25. Madsen, H.O., V. Videm, A. Svejgaard, J.L. Svennevig, and P. Garred. 1998. Association of mannose-binding-lectin deficiency with severe atherosclerosis. Lancet. 352:959-960.
26. Rugonfalvi-Kiss, S., V. Endresz, H.O. Madsen, K. Burian, J. Duba, Z. Prohaszka, I. Karadi, L. Romics, E. Gonczol, G. Fust, and P. Garred. 2002. Association of Chlamydia pneumoniae with coronary artery disease and its progression is dependent on the modifying effect of mannose-binding lectin. Circulation. 106:1071-1076.
27. Best, L.G., M. Davidson, K.E. North, J.W. MacCluer, Y. Zhang, E.T. Lee, B.V. Howard, S. DeCroo, and R.E. Ferrell. 2004. Prospective analysis of mannose-binding lectin genotypes and coronary artery disease in American Indians: the Strong Heart Study. Circulation. 109:471-475.
28. Öhlenschlaeger T., P. Garred, H.O. Madsen, and S. Jacobsen. 2004. Mannose-binding lectin variant alleles and the risk of arterial thrombosis in systemic lupus erythematosus. N. Engl. J. Med. 351:260-267.
29. Albert, M.A., N. Rifai, and P.M. Ridker. 2001. Plasma levels of cystatin-C and mannose binding protein are not associated with risk of developing systemic atherosclerosis. Vasc. Med. 6:145-149.
30. Dahl, M., A. Tybjaerg-Hansen, P. Schnohr, and E.G. Nordestgaard. 2004. A population-based study of morbidity and mortality in mannose-binding lectin deficiency. J. Exp. Med. 199:1391-1399.
31. Hansen, T.K., L. Tarnow, S. Thiel, R. Steffensen, C.D. Stehouwer, C.G. Schalkwijk, H.H. Parang, and A. Flyvbjerg. 2004. Association between mannose-binding lectin and vascular complications in type 1 diabetes. Diabetes. 53:1570-1576.
32. Jonsdottir, L.S., N. Sigfusson, V. Gudnason, H. Sigvaldason, and G. Thorgeirsson. 2002. Do lipids, blood pressure, diabetes, and smoking confer equal risk of myocardial infarction in women as in men? The Reykjavik Study. J. Cardiovasc. Risk. 9:67-76.
33. Swanson, A.F., R.A. Ezekowitz, A. Lee, and C.C. Kuo. 1998. Human mannose-binding protein inhibits infection of HeLa cells by Chlamydia trachomatis. Infect. Immun. 66:1607-1612.
34. Shoenfeld, Y., D. Harats, and G. Wick, editors. 2001. Atherosclerosis and Autoimmunity. Elsevier, New York. 370 pp.
35. Hansen, T.K., S. Thiel, R. Dall, A.M. Rosenfalck, P. Trainer, A. Flyvbjerg, J.O. Jorgensen, and J.S. Christiansen. 2001. GH strongly affects serum concentrations of mannan-binding lectin: evidence for a new IGF-I independent immunomodulatory effect of GH. J. Clin. Endocrinol. Metab. 86:5383-5388.
36. Gravholt, C.H., R. Leth-Larsen, A.L. Lauridsen, S. Thiel, T.K. Hansen, U. Holmskov, R.W. Naeraa, and J.S. Christiansen. 2004. The effects of GH and hormone replacement therapy on serum concentrations of mannan-binding lectin, surfactant protein D and vitamin D binding protein in Turner syndrome. Eur. J. Endocrinol. 150:355-362.
37. Igarashi, J., and T. Michel. 2001. More sweetness than light? A search for the causes of diabetic vasculopathy. J. Clin. Invest. 108:1425-1427.
38. Royle, L., A. Roos, D.J. Harvey, M.R. Wormald, D. van Gijlswijk-Janssen, El-R.M. Redwan, I.A. Wilson, M.R. Daha, R.A. Dwek, and P.M. Rudd. 2003. Secretory IgA N- and O-glycans provide a link between the innate and adaptive immune systems. J. Biol. Chem. 278:20140-20153.
39. Malhotra, R., M.R. Wormald, P.M. Rudd, P.B. Fischer, R.A. Dwek, and R.B. Sim. 1995. Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Nat. Med. 1:237-243.
40. Swaminathan, N., and F. Aladjem. 1976. The monosaccharide composition and sequence of the carbohydrate moiety of human serum low density lipoproteins. Biochemistry. 15:1516-1522.
41. Lee, P., and W. Breckenridge. 1976. Isolation and carbohydrate composition of glycopeptides of human apo low-density lipoprotein from normal and type II hyperlipoproteinemic subjects. Can. J. Biochem. 54:829-833.
42. Tertov, V.V., I.A. Sobenin, A.G. Tonevitsky, A.N. Orekhov, and V.M. Smirnov. 1990. Isolation of atherogenic modified (desialylated) low density lipoprotein from blood of atherosclerotic patients: separation from native lipoprotein by affinity chromatography. Biochem. Biophys. Res. Commun. 167:1122-1127.
43. Mustafa, A., S. Nityanand, L. Berglund, H. Lithell, and A.K. Lefvert. 2000. Circulating immune complexes in 50-year-old men as a strong and independent risk factor for myocardial infarction. Circulation. 102:576-2581.
44. Holvoet, P., J. Vanhaecke, S. Janssens, F. Van de Werf, and D. Collen. 1998. Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. Circulation. 98:1487-1494.
45. Lopes-Virella, M.F., G. Virella, T.J. Orchard, S. Koskinen, R.W. Evans, D.J. Becker, and K.Y. Forrest. 1999. Antibodies to oxidized LDL and LDL-containing immune complexes as risk factors for coronary artery disease in diabetes mellitus. Clin. Immunol. 90:165-172.
46. Sobal, G., J. Menzel, and H. Sinzinger. 2000. Why is glycated LDL more sensitive to oxidation than native LDL? A comparative study. Prostaglandins Leukot. Essent. Fatty Acids. 63:177-186.
47. Cambi, A., and C.G. Figdor. 2003. Dual function of C-type lectin-like receptors in the immune system. Curr. Opin. Cell Biol. 15:539-546.
48. de Nigris, F., A. Lerman, L.J. Ignarro, S. Williams-Ignarro, V. Sica, A.H. Baker, L.O. Lerman, Y.J. Geng, and C. Napoli. 2003. Oxidation-sensitive mechanisms, vascular apoptosis and atherosclerosis. Trends Mol. Med. 9:351-359.
49. Valdimarsson, H., T. Vikingsdottir, P. Bang, S. Saevarsdottir, J.E. Gudjonsson, O. Oskarsson, M. Christiansen, L. Blou, I. Laursen, and C. Koch. 2004. Human plasma-derived mannose-binding lectin: a phase I safety and pharmacokinetic study. Scand. J. Immunol. 59:97-102.
50. 1988. The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. WHO MONICA Project Principal Investigators. J. Clin. Epidemiol. 41:105-114.